Balance Sheet Cizzle Biotechnology Holdings Plc

Equities

CIZ

GB00BNG2VN02

Biotechnology & Medical Research

Market Closed - London S.E. Other stock markets 09:05:27 05/06/2026 pm IST			5-day change	1st Jan Change
3.050 ^GBX	-3.17%		+3.39%	+96.77%

07/05	WINNERS & LOSERS: S4 Capital hit by "client caution"; NAHL in profit	AN
06/05	Cizzle Biotechnology to Issue New Shares Following Loan Note Conversion Notice	MT

c07285b0f91b9ebe4a26.M31VJW1yEM_AcX-L_eYVHDVo4PUeFINi25fQXRDGfiE.awgwai4kYaOSXC3ksd8hdEcq1IxBWM4XqNGeCVeBOXBeFGJQHgRa-_k6DA

Published financial data: CIZZLE BIOTECHNOLOGY HOLDINGS PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	-	-	-	-	-
Total Revenues	-	-	-	-	-
Cost of Goods Sold, Total	-	-	-	-	-
Gross Profit	-	-	-	-	-
Selling General & Admin Expenses, Total	6L	10L	10L	9L	7L
R&D Expenses	2L	-	-	-	-
Other Operating Expenses	-	-	-	-	-
Other Operating Expenses, Total	8L	10L	10L	9L	7L
Operating Income	-8L	-10L	-10L	-9L	-7L
Interest And Investment Income	-	-	-	-	-
Net Interest Expenses	-	-	-	-	-
Other Non Operating Income (Expenses)	-53T	-	-	80T	2T
EBT, Excl. Unusual Items	-9L	-10L	-10L	-8L	-7L
Merger & Related Restructuring Charges	-31.07L	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-7L	-13.91L	-22T
Gain (Loss) On Sale Of Assets	-	-	44T	-	-
Other Unusual Items	-	-	-1L	-	-
EBT, Incl. Unusual Items	-39.58L	-10L	-17.63L	-21.87L	-8L
Income Tax Expense	-37T	-51T	-46T	-21T	-60T
Earnings From Continuing Operations	-39.21L	-9L	-17.17L	-21.66L	-7L
Net Income to Company	-39.21L	-9L	-17.17L	-21.66L	-7L
Net Income - (IS)	-39.21L	-9L	-17.17L	-21.66L	-7L
Net Income to Common Incl Extra Items	-39.21L	-9L	-17.17L	-21.66L	-7L
Net Income to Common Excl. Extra Items	-39.21L	-9L	-17.17L	-21.66L	-7L
Per Share Items
Net EPS - Basic	-0.02	-0	-0	-0.01	-0
Basic EPS - Continuing Operations	-0.02	-0	-0	-0.01	-0
Basic Weighted Average Shares Outstanding	16Cr	29Cr	36Cr	39Cr	40Cr
Net EPS - Diluted	-0.02	-0	-0	-0.01	-0
Diluted EPS - Continuing Operations	-0.02	-0	-0	-0.01	-0
Diluted Weighted Average Shares Outstanding	16Cr	29Cr	36Cr	39Cr	40Cr
Normalized Basic EPS	-0	-0	-0	-0	-0
Normalized Diluted EPS	-0	-0	-0	-0	-0
Supplemental Items
EBITDA	-	-	-	-	-
EBITA	-8L	-10L	-10L	-9L	-7L
EBIT	-8L	-10L	-10L	-9L	-7L
Effective Tax Rate - (Ratio)	0.93	5.3	2.61	0.96	7.99
Total Current Taxes	-	-	-	-	-
Normalized Net Income	-5L	-6L	-6L	-5L	-5L
Supplemental Operating Expense Items
General and Administrative Expenses	5L	10L	10L	9L	7L
Research And Development Expense From Footnotes	2L	3L	2L	2L	2L
Stock-Based Comp., G&A Exp. (Total)	31.4L	1L	3L	2L	22T
Total Stock-Based Compensation	31.4L	1L	3L	2L	22T

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	9L	5L	1L	4L	1L
Trading Asset Securities, Total	-	-	14.13L	22T	-
Total Cash And Short Term Investments	9L	5L	15.57L	4L	1L
Other Receivables	51T	95T	1L	76T	1L
Total Receivables	51T	95T	1L	76T	1L
Inventory	-	-	-	2T	-
Prepaid Expenses	29T	12T	27T	27T	25T
Other Current Assets, Total	-	1L	-	-	-
Total Current Assets	10L	7L	16.93L	5L	2L
Gross Property Plant And Equipment	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-
Net Property Plant And Equipment	-	-	-	-	2T
Long-term Investments	-	-	-	-	-
Other Intangibles, Total	2L	20.8L	-	-	-
Total Assets	11.55L	27.85L	16.93L	5L	2L
Liabilities
Accounts Payable, Total	1L	41T	92T	13T	52T
Accrued Expenses, Total	1L	1L	94T	4L	5L
Short-term Borrowings	-	-	-	-	-
Unearned Revenue Current, Total	-	-	-	-	-
Total Current Liabilities	2L	1L	2L	4L	6L
Unearned Revenue Non Current	-	-	-	-	-
Total Liabilities	2L	1L	2L	4L	6L
Common Stock, Total	34.93L	35.02L	35.04L	35.07L	35.07L
Additional Paid In Capital	3.26Cr	3.49Cr	3.53Cr	3.59Cr	3.59Cr
Retained Earnings	-55.17L	-61.53L	-78.7L	-1Cr	-1.06Cr
Comprehensive Income and Other	-2.96Cr	-2.96Cr	-2.95Cr	-2.93Cr	-2.92Cr
Total Common Equity	9L	26.4L	15.07L	82T	-3L
Total Equity	9L	26.4L	15.07L	82T	-3L
Total Liabilities And Equity	11.55L	27.85L	16.93L	5L	2L
Supplemental Items
ECS Total Shares Outstanding on Filing Date	25Cr	34Cr	36Cr	40Cr	40Cr
ECS Total Common Shares Outstanding	25Cr	34Cr	36Cr	40Cr	40Cr
Book Value / Share	0	0.01	0	0	-0
Tangible Book Value	7L	6L	15.07L	82T	-3L
Tangible Book Value Per Share	0	0	0	0	-0
Total Debt	0	0	0	0	0
Net Debt	-9L	-5L	-15.57L	-4L	-1L
Account Code - Inventory Valuation	3	3	3	3	5
Machinery, Total	-	-	-	-	-
Full Time Employees	4	4	4	4	5

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-39.21L	-9L	-17.17L	-21.66L	-7L
Amortization of Deferred Charges, Total - (CF)	32T	-	-	-	-
(Gain) Loss From Sale Of Asset	-	-	-44T	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	7L	13.91L	22T
Stock-Based Compensation (CF)	3L	1L	3L	2L	20T
Other Operating Activities, Total	27.67L	-51T	1L	24T	-22T
Change In Accounts Receivable	7T	16T	-24T	6T	-3T
Change In Inventories	-	-	-	2T	2T
Change In Accounts Payable	-2L	-73T	13T	2L	2L
Cash from Operations	-10.09L	-9L	-6L	-4L	-5L
Capital Expenditure	-	-	-	-	-2T
Cash Acquisitions	46T	-	-	-	-
Sale (Purchase) of Intangible assets	-2L	-	-	-	-
Other Investing Activities, Total	-	-1L	-	-	-
Cash from Investing	-2L	-1L	-	-	-2T
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	-	-	2L
Total Debt Issued	-	-	-	-	2L
Short Term Debt Repaid, Total	-10T	-	-	-	-
Total Debt Repaid	-10T	-	-	-	-
Issuance of Common Stock	22L	7L	4L	7L	-
Other Financing Activities, Total	-2L	-80T	-45T	-72T	-
Cash from Financing	20.31L	6L	3L	6L	2L
Net Change in Cash	9L	-4L	-3L	2L	-2L
Supplemental Items
Cash Income Tax Paid (Refund)	-	-	-41T	-46T	-38T
Levered Free Cash Flow	26.06L	-7L	-2L	-1L	-3L
Unlevered Free Cash Flow	26.06L	-7L	-2L	-1L	-3L
Change In Net Working Capital	-1L	2L	-1L	-3L	-2L
Net Debt Issued / Repaid	-10T	-	-	-	2L

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-85.62	-30.55	-27.24	-50.11	-123.98
Return on Total Capital	-106.23	-33.65	-29.42	-68.91	354.17
Return On Equity %	-844.13	-50.99	-82.81	-272.62	535.66
Return on Common Equity	-844.13	-50.99	-82.81	-272.62	535.66
Margin Analysis
Gross Profit Margin %	-	-	-	-	-
SG&A Margin	-	-	-	-	-
EBITDA Margin %	-	-	-	-	-
EBITA Margin %	-	-	-	-	-
EBIT Margin %	-	-	-	-	-
Income From Continuing Operations Margin %	-	-	-	-	-
Net Income Margin %	-	-	-	-	-
Net Avail. For Common Margin %	-	-	-	-	-
Normalized Net Income Margin	-	-	-	-	-
Asset Turnover
Asset Turnover	-	-	-	-	-
Fixed Assets Turnover	-	-	-	-	-
Short Term Liquidity
Current Ratio	4.38	4.86	9.1	1.2	0.42
Quick Ratio	4.25	3.95	8.96	1.13	0.37
Operating Cash Flow to Current Liabilities	-4.63	-6.01	-3.44	-0.87	-0.85
Average Days Payable Outstanding	-	-	-	-	-
Long Term Solvency
Total Debt/Equity	-	-	-	-	-
Total Debt / Total Capital	-	-	-	-	-
Total Liabilities / Total Assets	18.87	5.21	10.99	83.33	238.78
Net Debt / EBITDA	-	-	-	-	-
Net Debt / (EBITDA - Capex)	-	-	-	-	-
Growth Over Prior Year
Gross Profit, 1 Yr. Growth %	-	-	-	-	-
EBITDA, 1 Yr. Growth %	-	-	-	-	-
EBITA, 1 Yr. Growth %	5.6T	13.16	1.35	-10.25	-16.74
EBIT, 1 Yr. Growth %	5.6T	13.16	1.35	-10.25	-16.74
Earnings From Cont. Operations, 1 Yr. Growth %	27.91T	-76.74	88.27	26.15	-68.1
Net Income, 1 Yr. Growth %	27.91T	-76.74	88.27	26.15	-68.1
Normalized Net Income, 1 Yr. Growth %	5.98T	13.16	1.35	-18.44	-8.42
Diluted EPS Before Extra, 1 Yr. Growth %	-13.83	-87.19	54.12	15.88	-68.82
Net Property, Plant and Equip., 1 Yr. Growth %	-	-	-	-	-
Total Assets, 1 Yr. Growth %	11.45T	141.13	-39.21	-70.94	-50.2
Tangible Book Value, 1 Yr. Growth %	-9.31T	-24.02	169.11	-94.56	-514.63
Common Equity, 1 Yr. Growth %	-11.81T	181.75	-42.92	-94.56	-514.63
Cash From Operations, 1 Yr. Growth %	6.21T	-13.58	-26.72	-43.98	38.55
Levered Free Cash Flow, 1 Yr. Growth %	-26.33T	-126.19	-74.62	-39.47	171
Unlevered Free Cash Flow, 1 Yr. Growth %	-26.33T	-126.19	-74.62	-39.47	171
Compound Annual Growth Rate Over Two Years
Gross Profit, 2 Yr. CAGR %	-	-	-	-	-
EBITDA, 2 Yr. CAGR %	-	-	-	-	-
EBITA, 2 Yr. CAGR %	506.28	729.37	7.09	-4.62	-13.46
EBIT, 2 Yr. CAGR %	506.28	729.37	7.09	-4.62	-13.46
Earnings From Cont. Operations, 2 Yr. CAGR %	1.24T	707.11	-33.83	54.11	-36.56
Net Income, 2 Yr. CAGR %	1.24T	707.11	-33.83	54.11	-36.56
Normalized Net Income, 2 Yr. CAGR %	526.1	729.37	7.09	-9.08	-13.58
Diluted EPS Before Extra, 2 Yr. CAGR %	-40.56	-66.77	-55.56	33.64	-39.89
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	-	-	-
Total Assets, 2 Yr. CAGR %	737.24	1.57T	21.07	-57.97	-61.96
Tangible Book Value, 2 Yr. CAGR %	954.25	736.66	43	-61.73	-52.5
Common Equity, 2 Yr. CAGR %	1.09T	1.72T	26.82	-82.38	-52.5
Cash From Operations, 2 Yr. CAGR %	1.09T	638.24	-20.42	-35.93	-11.9
Levered Free Cash Flow, 2 Yr. CAGR %	4.84T	723.54	-74.22	-60.81	28.84
Unlevered Free Cash Flow, 2 Yr. CAGR %	4.84T	723.54	-74.22	-60.81	28.84
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	-	-
Gross Profit, 3 Yr. CAGR %	-	-	-	-	-
EBITDA, 3 Yr. CAGR %	-	-	-	-	-
EBITA, 3 Yr. CAGR %	551.03	253.99	311.57	0.97	-8.78
EBIT, 3 Yr. CAGR %	551.03	253.99	311.57	0.97	-8.78
Earnings From Cont. Operations, 3 Yr. CAGR %	1.01T	247.64	396.84	-17.95	-8.84
Net Income, 3 Yr. CAGR %	1.01T	247.64	396.84	-17.95	-8.84
Normalized Net Income, 3 Yr. CAGR %	565.69	253.99	311.57	-2.2	-8.86
Diluted EPS Before Extra, 3 Yr. CAGR %	38.51	-64.36	-44.59	-38.83	-17.73
Total Assets, 3 Yr. CAGR %	186.62	452.9	453.2	-24.76	-55.53
Tangible Book Value, 3 Yr. CAGR %	196.27	338.74	473.25	-51.9	-15.32
Common Equity, 3 Yr. CAGR %	220.96	635.66	473.25	-55.6	-49.5
Cash From Operations, 3 Yr. CAGR %	435.63	397.73	241.82	-29.21	-17.14
Levered Free Cash Flow, 3 Yr. CAGR %	598.61	757.97	158.18	-65.74	-25.04
Unlevered Free Cash Flow, 3 Yr. CAGR %	598.61	757.97	158.18	-65.74	-25.04
Compound Annual Growth Rate Over Five Years
EBITA, 5 Yr. CAGR %	32.68	47.09	220.37	109.49	120.58
EBIT, 5 Yr. CAGR %	32.68	47.09	220.37	109.49	120.58
Earnings From Cont. Operations, 5 Yr. CAGR %	89.76	50.48	258.84	151.08	118.11
Net Income, 5 Yr. CAGR %	89.76	50.48	258.84	151.08	118.11
Normalized Net Income, 5 Yr. CAGR %	34.42	47.09	220.53	105.52	120.46
Diluted EPS Before Extra, 5 Yr. CAGR %	-45.49	-61.63	-12.1	-39.53	-42.75
Total Assets, 5 Yr. CAGR %	38.77	130.17	103.05	97.25	89.6
Tangible Book Value, 5 Yr. CAGR %	36.14	78.13	121.38	65.37	111.68
Common Equity, 5 Yr. CAGR %	42.84	142.9	121.38	65.37	111.68
Cash From Operations, 5 Yr. CAGR %	-	40.69	149.83	119.21	98.73
Levered Free Cash Flow, 5 Yr. CAGR %	-	41.58	86.18	149.66	95.52
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	41.58	86.18	149.66	95.52